Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: BG Group drags FTSE 100 lower, Syria concerns weigh

Mon, 09th Sep 2013 17:44

The FTSE 100 dropped into the red on Monday, pulling back after hitting a three-week high the previous session, as heavy falls from natural gas giant BG Group and ongoing concerns about Syria pressured stocks lower.London's benchmark index finished 16.59 points lower at 6,530.74, falling 0.25% from Friday's close of 6,547.33 which was its highest closing price since August 14th.Syria continues to be in focus this week ahead of a vote by US Congress over whether or not to proceed with a military attack after last month's alleged use of chemical weapons by Bashar Al-Assad's regime. Tensions at the G20 Summit escalated last week after Vladimir Putin said Russia would "assist" Syria if it was attacked by the US, just as President Barack Obama was trying to rally for support from global leaders for an intervention.Talks between US Secretary of State John Kerry and UK Foreign Secretary William Hague also caught the headlines this morning after Hague said the objectives and efforts of the US and UK "remain closely aligned". Kerry said that the relationship between the two countries was not affected by the UK's decision not engage in a military attack, but said that "the risk of not acting is greater than the risk of acting"."Despite the UK watching the Syria affair from the side-lines after the Prime Minister failed to secure parliamentary support for action, fallout from this vote will still be felt in the UK markets with oil prices and a potential flight to quality affecting both equity and Gilts," said Financial Sales Trader Alex Conroy.Uncertainty regarding Federal Reserve monetary policy also prompted traders to adopt a cautious approach in the aftermath of Friday's disappointing jobs report. A worse-than-expected rise in non-farm payrolls in August sparked speculation that the US central bank could hold off from tapering its quantitative easing (QE) programme until later on in the year. However, the unemployment rate fell last month from 7.4% to 7.3%.Chinese exports rise, Japan GDP revised upAsian markets performed well overnight after Chinese trade and inflation numbers brightened the third-quarter outlook for the world's second-largest economy. Chinese exports rose by a stronger-than-expected 7.2% in August and imports jumped by 7%, while the annual rate of consumer price inflation eased from 2.7% to 2.6%. Writing in Monday's Financial Times Chinese Premier Li Keqiang said that his country will stay the course on sustainable growth, by continuing to promote reforms, with an aim of meeting its 7.5% lower bound for gross domestic product (GDP) growth this year. Meanwhile, second-quarter GDP estimates in Japan were revised higher from 0.6% to 0.9%, as confidence grows in Prime Minister Shinzo Abe's so-called 'Abenomics'. While this was slightly lower than predictions, this data - along with the news that Tokyo will host the 2020 Olympics - gave the Nikkei 225 index a strong boost.FTSE 100: BG drops after cutting production guidanceOil and gas group BG was a heavy faller after lowering its 2014 production milestones due to the instability in Egypt, delays to the start-up of production in Norway and low natural gas prices in the US.Sugar and food group Tate & Lyle wasn't far behind after UBS downgraded the stock from 'neutral' to 'sell', saying that its current valuation is too high and does not reflect that "sucralose prices continue to decline as 'generic' competitors improve product quality and access greater scale".Food ingredients peer and retail group Associated British Foods was also lower despite saying a strong finish to the year from Primark will help it deliver adjusted operating profit ahead of expectations for the second half. Instead, the market was focusing on comments about low EU sugar prices next year.Mining stocks were putting in a mixed performance despite the strong data from top metals user China. Analysts at Citigroup said today that mining stocks could benefit from "additional short-term price momentum in the sector on positive rhetoric" following the category's underperformance so far this year compared with the UK market. "However, valuations are now looking more fully priced and we think the rally will fade into year end." The bank named Rio Tinto and Glencore Xstrata as its favoured stocks in the UK diversified mining sector, both of which were making gains today.GlaxoSmithKline declined after confirming it has reached an agreement to sell its Lucozade and Ribena brands to Japanese firm Suntory Beverage & Food for £1.35bn in cash. The company said that now is the right time to sell "as we increase the focus of our Consumer Healthcare business and execute the delivery of our late stage pipeline of pharmaceuticals and vaccines".FTSE 250: Icap and CSR lead gainsICAP is in talks about a settlement over its role in the Libor rate-rigging scandal which could see it pay about £70m ($109m) to British and US regulators, Sky News reported.Broker Liberum lited its target on CSR to buy, with a 550p price target. FTSE 100 - RisersARM Holdings (ARM) 917.50p +2.80%TUI Travel (TT.) 347.40p +2.72%Aviva (AV.) 399.80p +2.25%Burberry Group (BRBY) 1,635.00p +2.19%Lloyds Banking Group (LLOY) 76.78p +1.82%Kingfisher (KGF) 413.20p +1.67%ITV (ITV) 177.40p +1.66%Legal & General Group (LGEN) 193.80p +1.63%Whitbread (WTB) 3,216.00p +1.55%British Land Co (BLND) 557.50p +1.46%FTSE 100 - FallersBG Group (BG.) 1,217.00p -5.07%Tate & Lyle (TATE) 779.50p -3.41%Associated British Foods (ABF) 1,818.00p -1.78%Randgold Resources Ltd. (RRS) 4,914.00p -1.50%Petrofac Ltd. (PFC) 1,397.00p -1.34%Royal Dutch Shell 'A' (RDSA) 2,052.00p -1.27%Standard Chartered (STAN) 1,455.50p -1.12%United Utilities Group (UU.) 673.00p -1.10%Tullow Oil (TLW) 1,059.00p -1.03%HSBC Holdings (HSBA) 701.10p -1.02%FTSE 250 - RisersICAP (IAP) 417.80p +4.58%CSR (CSR) 517.50p +4.55%Barratt Developments (BDEV) 328.20p +4.36%888 Holdings (888) 146.90p +4.18%Enterprise Inns (ETI) 150.40p +3.72%Perform Group (PER) 523.50p +3.66%Bank of Georgia Holdings (BGEO) 1,810.00p +3.13%Debenhams (DEB) 104.50p +2.96%Halfords Group (HFD) 393.70p +2.79%Computacenter (CCC) 538.00p +2.77%FTSE 250 - FallersXaar (XAR) 760.00p -4.34%Petra Diamonds Ltd.(DI) (PDL) 122.90p -3.46%Salamander Energy (SMDR) 125.00p -3.40%Berendsen (BRSN) 906.50p -2.89%Bumi (BUMI) 211.20p -2.85%Kenmare Resources (KMR) 28.36p -2.54%Workspace Group (WKP) 430.60p -2.36%BTG (BTG) 368.00p -2.34%Brown (N.) Group (BWNG) 557.00p -2.28%Imagination Technologies Group (IMG) 287.10p -2.18%BC
More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.